Jyrki Heino
jyheino@utu.fi +358 29 450 2197 +358 50 523 8351 Tykistökatu 6 Turku |
- Cancer-associated fibroblasts mediate resistance to neoadjuvant therapy in breast cancer (2024)
- Clinical and translational medicine
- Collagen prolyl 4-hydroxylase isoenzymes I and II have sequence specificity towards different X-Pro-Gly triplets (2024)
- Matrix Biology
- Dual-ligand PROTACS mediate superior target protein degradation in vitro and therapeutic efficacy in vivo (2024)
- Chemical Science
- Embigin deficiency leads to delayed embryonic lung development and high neonatal mortality in mice (2024)
- iScience
- Pelophen B is a non-taxoid binding microtubule-stabilizing agent with promising preclinical anticancer properties (2024)
- Scientific Reports
- Protocol to study early lung developmental branching in mouse embryos using explant culture (2024)
- STAR protocols
- Inhibition of TGF-β signaling, invasion, and growth of cutaneous squamous cell carcinoma by PLX8394 (2023)
- Oncogene
- Integrins α1β1 and α2β1: The Generalist Collagen Receptors (2023) Integrins in Health and Disease Heino Jyrki, Siljamäki Elina
- What does it take to be a collagen receptor? (2023)
- Matrix Biology
- C1r Upregulates Production of Matrix Metalloproteinase-13 and Promotes Invasion of Cutaneous Squamous Cell Carcinoma (2022)
- Journal of Investigative Dermatology



